Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Research and Development: Page 2
AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
By
LabPulse.com staff writers
Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care viral testing system.
March 4, 2024
Novartis presents first results of SMART spinal muscular atrophy study
By
LabPulse.com staff writers
Company presents new data from a clinical study, called the SMART study, of its gene therapy in previously treated patients and a broader patient population.
March 5, 2024
BioMĂ©rieux, FDA to collaborate on combating food-borne pathogens
By
LabPulse.com staff writers
BioMĂ©rieux has entered into a strategic research collaboration with the U.S. Food and Drug Administration (FDA) to develop technologies to improve the detection and characterization of food-borne pathogens.
March 1, 2024
Alzheimerâs study results show correlation between blood-based biomarkers and amyloid plaques
By
LabPulse.com staff writers
The first results from the Bio-Hermes study have been released, showing a strong correlation between several blood-based and digital biomarkers with the presence of amyloid plaques in the brain, a diagnostic hallmark of Alzheimer's disease (AD).
March 1, 2024
MD Anderson Cancer Center, C-Biomex collaborate on CA9-targeting radioligand
By
Matt Limb
The University of Texas MD Anderson Cancer Center has signed an agreement with South Korean company C-Biomex to co-develop CBT-001, a radioligand targeting the CA9 cancer biomarker.
February 29, 2024
National Cancer Institute launches network to evaluate cancer screening technologies
By
LabPulse.com staff writers
In support of the Biden-Harris administrationâs Cancer Moonshot initiative, the U.S. National Institutes of Health has launched the Cancer Screening Research Network, a clinical trial network for evaluating emerging cancer screening technologies.
February 22, 2024
âRemarkableâ results in lupus patients spark speculation CAR-T may cure autoimmunity
By
Nick Paul Taylor
The generation of âremarkableâ results in lupus patients has sparked speculation about the potential for chimeric antigen receptor T-cell (CAR-T cell) therapy to cure autoimmune diseases.
February 23, 2024
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test
By
LabPulse.com staff writers
CARB-X will award up to $1.8 million to biotech firm Visby Medical to develop a portable rapid polymerase chain reaction test to detect
Neisseria gonorrhoeae
, the pathogen that causes gonorrhea, including its susceptibility to ciprofloxacin.
February 8, 2024
U.K. trial for mRNA-based cancer therapy begins
By
Matt Limb
Cancer patients in the U.K. are receiving an experimental mRNA therapy designed to help their bodies recognize and fight cancer cells.
February 7, 2024
BioMĂ©rieux, UPitt in new three-year agreement
By
LabPulse.com staff writers
BioMĂ©rieux and the University of Pittsburgh have entered into a three-year diagnostics research agreement, the university announced in Pittwire.
February 2, 2024
Sensorion receives clinical trial approval for congenital deafness gene therapy
By
LabPulse.com staff writers
French biotech firm Sensorion has received approval to initiate a phase I and II clinical trial in France of SENS-501 (the OTOF-GT program), its gene therapy for gene-mediated hearing impairment.
January 22, 2024
IGI, Danaher launch CRISPR gene therapy research center
By
LabPulse.com staff writers
Danaher and the Innovative Genomics Institute (IGI) have launched a collaborative research center aimed at developing CRISPR-based gene therapies for a wide array of diseases.
January 12, 2024
Previous Page
Page 2 of 38
Next Page